Clinical Genitourinary Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2024-05-10 ms9000000505019838 来自北京

审稿速度:2.0
经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2024-04-21 ms9000000505019838 来自北京

快1个月了，还是with editor

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2020-11-16 lovetcm

审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0
偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌
经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受

泌尿生殖系统癌症的检测，诊断，预防和治疗

重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。

是否OA开放访问：No

Gold Open Access 费用：USD 2950/¥20574.48

支持Green OA即无版面费

85 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2021-12-28 rayms

我们做研究时最常见或撰写的SCI文章类型是什么？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2021-12-28 Mia

如何判断SCI文章类型？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2016-12-09 xiaoxiaoxiao

审稿速度:3.0 | 投稿命中率:25.0
经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。

239 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2020-01-14 1356693635

请问接受实验性论文么ricocao 2019-12-14 发表::
接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表:
未送审，投稿10天直接接收

ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收

102 0

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2019-12-14 ricocao

审稿速度:1.0 | 投稿命中率:95.0
经验分享：未送审，投稿10天直接接收

126 0

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2019-09-02 hellofish

两个月了催了好几次都说马上审稿就是不送审撤稿

140 0

[GetPortalCommentsPageByObjectIdResponse(id=2203938, encodeId=70eb2203938a7, content=审稿速度:2.0 经验分享：with Editor 一个多月，然后DIP，然后第二天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Fri May 10 19:28:43 CST 2024, time=2024-05-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199600, encodeId=19d8219960093, content=快1个月了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f9229399, createdName=ms9000000505019838, createdTime=Sun Apr 21 16:28:29 CST 2024, time=2024-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=899529, encodeId=9a658995291c, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：泌尿系肿瘤;膀胱癌;肾癌 经验分享：Clinical Genitourinary Cancer冷门期刊1个审稿人同意就能接受 泌尿生殖系统癌症的检测，诊断，预防和治疗 重点：临床研究和机制方法、药物敏感性和耐药性、基因和反义疗法、病理，标志物和预后指标、化学预防策略、多模态疗法以及各种方法的整合。 是否OA开放访问：No Gold Open Access 费用：USD 2950/¥20574.48 支持Green OA即无版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Nov 16 09:47:00 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100045, encodeId=3b74110004508, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100046, encodeId=ca5e110004609, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530402, encodeId=8a10530402d3, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：9月19号投稿，一直with editor，其间，一个月的时候发邮件询问，未回复。此后，每个星期都发邮件，一直没回复。一直with editor，今天12月9号，拒稿。模板拒稿，拒稿信文章题目都没有，估计就是直接复制粘贴的那种。个人经验，投稿时请慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4531627437, createdName=xiaoxiaoxiao, createdTime=Fri Dec 09 17:51:00 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583276, encodeId=8f185832e67b, content=请问接受实验性论文么ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收ricocao 2019-12-14 00:00:00 发表: 未送审，投稿10天直接接收, beContent=ricocao 2019-12-14 发表:: 接收率：约95% 审稿时间：约1个月未送审，投稿10天直接接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34324789126, createdName=1356693635, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581460, encodeId=be285814605e, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：未送审，投稿10天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/77df07ebaf4d4885ae865715f9fe29cc/1efc6ce8a2764f1d919493543079217e.jpg, createdBy=b54b2424151, createdName=ricocao, createdTime=Sat Dec 14 00:00:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575743, encodeId=5aa45e5743f9, content=两个月了催了好几次都说马上审稿就是不送审撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574857, encodeId=89515e48574a, content=以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vCPUAaeXbJNMIjVg5OibcmUiaXbSqPu6NwX6LibcSicbibnJDPg7dktOoW34y8cFsnmcOrC5HF2r8yAFJJYlqjEZibMA/132, createdBy=34dc2536947, createdName=hellofish, createdTime=Fri Aug 16 00:00:00 CST 2019, time=2019-08-16, status=1, ipAttribution=)]

2019-08-16 hellofish

以后在不投了准备撤稿一个多月了还是with,Editor 催了一直说在处理

113 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务